FLNA Filana Therapeutics, Inc. stock chart & analysis
Conviction 45HealthcareScan · Tue, Nov 10, 2026Filana Therapeutics, Inc. (FLNA) closed at $0.4891 (-0.65%) on Nov 10, 2026. Price is below its 50-day. RSI(14) 33, -78.4% from its 52-week high, -76.6% year to date. Sector: Healthcare · Pharmaceutical Preparations.
Why FLNA moved
From the StockSetups movers recaps that covered FLNA, newest first. A recap states what was known that day.
- Close+37.9%
The catalyst is clear and significant.
Top Stock Movers Sept 22, 2026: LHSW, RAIN, GRML →
Financials as of Wed, Sep 30, 2026 · quarterly.
FLNA technical analysis
Trend
It closed 33.6% below the 50-day ($0.7368). ADX(14) at 21 points to a moderate trend.
Momentum
RSI(14) is 33, in the bearish half of its range. The MACD histogram is negative. A bullish MACD divergence is in place.
Volume and volatility
It trades about $225,508 a day on average. ATR(14) is $0.0572, 11.7% of price — its typical daily range. On-balance volume is trending down. Chaikin Money Flow (-0.24) shows distribution.
Key levels
The chart pattern's support is $0.5130 and its resistance $1.17. The 52-week range is $0.4252 to $2.27; price is 78.4% below the high and 15.0% above the low. The VWAP anchored at the 52-week high is $1.10, above price.
Performance
FLNA returned -17.7% (1 week), -36.4% (1 month), -47.6% (3 months), -59.2% (6 months), -76.6% (year to date).
About Filana Therapeutics, Inc.
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.
Pharmaceutical Preparations · Listed 2000 · 20 employees
SEC filings
EDGAR filings in FLNA · 8 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.